Ameriprise’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04B | Sell |
11,979,931
-15,355
| -0.1% | -$1.47M | 0.24% | 93 |
|
|
2025
Q4 | $1.15B | Sell |
11,995,286
-539,580
| -4% | -$52.4M | 0.26% | 75 |
|
|
2025
Q3 | $1.19B | Sell |
12,534,866
-2,062,814
| -14% | -$190M | 0.27% | 74 |
|
|
2025
Q2 | $1.27B | Sell |
14,597,680
-883,348
| -6% | -$74.9M | 0.31% | 64 |
|
|
2025
Q1 | $1.39B | Buy |
15,481,028
+3,461,221
| +29% | +$310M | 0.38% | 50 |
|
|
2024
Q4 | $960M | Buy |
12,019,807
+591,389
| +5% | +$51.2M | 0.25% | 78 |
|
|
2024
Q3 | $1.03B | Buy |
11,428,418
+513,706
| +5% | +$43.2M | 0.26% | 75 |
|
|
2024
Q2 | $859M | Sell |
10,914,712
-293,735
| -3% | -$24.1M | 0.23% | 86 |
|
|
2024
Q1 | $977M | Buy |
11,208,447
+108,079
| +1% | +$9.22M | 0.27% | 75 |
|
|
2023
Q4 | $915M | Sell |
11,100,368
-4,975,850
| -31% | -$379M | 0.27% | 75 |
|
|
2023
Q3 | $1.26B | Sell |
16,076,218
-540,170
| -3% | -$45.2M | 0.41% | 44 |
|
|
2023
Q2 | $1.46B | Buy |
16,616,388
+1,293,940
| +8% | +$111M | 0.46% | 41 |
|
|
2023
Q1 | $1.24B | Buy |
15,322,448
+3,443,262
| +29% | +$281M | 0.41% | 44 |
|
|
2022
Q4 | $923M | Buy |
11,879,186
+2,834,398
| +31% | +$230M | 0.32% | 73 |
|
|
2022
Q3 | $731M | Sell |
9,044,788
-437,176
| -5% | -$39.3M | 0.27% | 86 |
|
|
2022
Q2 | $850M | Sell |
9,481,964
-5,059,092
| -35% | -$513M | 0.3% | 76 |
|
|
2022
Q1 | $1.61B | Sell |
14,541,056
-1,220,485
| -8% | -$129M | 0.48% | 32 |
|
|
2021
Q4 | $1.63B | Sell |
15,761,541
-459,870
| -3% | -$53.3M | 0.45% | 37 |
|
|
2021
Q3 | $2.03B | Buy |
16,221,411
+622,069
| +4% | +$80.5M | 0.65% | 21 |
|
|
2021
Q2 | $1.94B | Sell |
15,599,342
-977,328
| -6% | -$123M | 0.6% | 24 |
|
|
2021
Q1 | $1.96B | Sell |
16,576,670
-316,884
| -2% | -$37.1M | 0.65% | 21 |
|
|
2020
Q4 | $1.98B | Sell |
16,893,554
-323,147
| -2% | -$35.6M | 0.7% | 16 |
|
|
2020
Q3 | $1.79B | Sell |
17,216,701
-1,122,977
| -6% | -$113M | 0.73% | 19 |
|
|
2020
Q2 | $1.68B | Sell |
18,339,678
-687,466
| -4% | -$65.9M | 0.72% | 19 |
|
|
2020
Q1 | $1.72B | Buy |
19,027,144
+1,291,193
| +7% | +$137M | 0.9% | 10 |
|
|
2019
Q4 | $2.01B | Buy |
17,735,951
+2,038,109
| +13% | +$224M | 0.84% | 17 |
|
|
2019
Q3 | $1.71B | Buy |
15,697,842
+3,489,025
| +29% | +$364M | 0.76% | 17 |
|
|
2019
Q2 | $1.19B | Sell |
12,208,817
-69,161
| -0.6% | -$6.31M | 0.53% | 30 |
|
|
2019
Q1 | $1.12B | Buy |
12,277,978
+143,592
| +1% | +$12.9M | 0.51% | 33 |
|
|
2018
Q4 | $1.1B | Sell |
12,134,386
-2,190,890
| -15% | -$205M | 0.55% | 29 |
|
|
2018
Q3 | $1.55B | Sell |
14,325,276
-1,014,862
| -7% | -$93.8M | 0.54% | 29 |
|
|
2018
Q2 | $1.31B | Buy |
15,340,138
+2,453,193
| +19% | +$205M | 0.58% | 25 |
|
|
2018
Q1 | $1.03B | Buy |
12,886,945
+3,751,053
| +41% | +$309M | 0.47% | 38 |
|
|
2017
Q4 | $738M | Sell |
9,135,892
-2,252,546
| -20% | -$180M | 0.34% | 61 |
|
|
2017
Q3 | $886M | Buy |
11,388,438
+1,954,535
| +21% | +$162M | 0.42% | 39 |
|
|
2017
Q2 | $837M | Buy |
9,433,903
+452,291
| +5% | +$38.1M | 0.42% | 39 |
|
|
2017
Q1 | $723M | Sell |
8,981,612
-803,617
| -8% | -$62.8M | 0.37% | 48 |
|
|
2016
Q4 | $697M | Sell |
9,785,229
-3,333,115
| -25% | -$262M | 0.38% | 48 |
|
|
2016
Q3 | $1.13B | Sell |
13,118,344
-435,766
| -3% | -$38M | 0.64% | 26 |
|
|
2016
Q2 | $1.18B | Sell |
13,554,110
-668,492
| -5% | -$54.1M | 0.69% | 25 |
|
|
2016
Q1 | $1.07B | Sell |
14,222,602
-666,586
| -4% | -$50.2M | 0.64% | 28 |
|
|
2015
Q4 | $1.15B | Sell |
14,889,188
-336,926
| -2% | -$25.4M | 0.67% | 28 |
|
|
2015
Q3 | $1.02B | Sell |
15,226,114
-247,741
| -2% | -$18.2M | 0.63% | 28 |
|
|
2015
Q2 | $1.15B | Sell |
15,473,855
-409,551
| -3% | -$31.3M | 0.65% | 22 |
|
|
2015
Q1 | $1.24B | Buy |
15,883,406
+6,794,058
| +75% | +$515M | 0.71% | 21 |
|
|
2014
Q4 | $656M | Buy |
9,089,348
+1,075,853
| +13% | +$74.7M | 0.38% | 59 |
|
|
2014
Q3 | $496M | Buy |
8,013,495
+2,826,680
| +54% | +$180M | 0.3% | 72 |
|
|
2014
Q2 | $331M | Sell |
5,186,815
-322,506
| -6% | -$19.6M | 0.2% | 126 |
|
|
2014
Q1 | $339M | Buy |
5,509,321
+63,660
| +1% | +$3.71M | 0.2% | 125 |
|
|
2013
Q4 | $313M | Buy |
5,445,661
+228,520
| +4% | +$13M | 0.19% | 130 |
|
|
2013
Q3 | $278M | Buy |
5,217,141
+113,819
| +2% | +$6.12M | 0.18% | 132 |
|
|
2013
Q2 | $263M | Buy |
+5,103,322
| New | +$252M | 0.18% | 124 |
|
Other funds holding MDT
VCM
VPM
Ameriprise's MDT Position: Q1 2026 in Review
Ameriprise reduced its Medtronic (MDT) stake by 0.13% in Q1 2026, selling an estimated $1.47M and leaving 11,979,931 shares worth $1.04B. The position accounts for 0.24% of the portfolio, ranked #93.
Ameriprise first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.03B in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Ameriprise held 11,979,931 shares of Medtronic worth $1.04B as of Q1 2026.
- Ameriprise sold 15,355 Medtronic shares in Q1 2026, an estimated $1.47M.
- Medtronic made up 0.24% of Ameriprise's portfolio in Q1 2026, its #93 holding.
- Ameriprise first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Medtronic position peaked at $2.03B in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.